When Lincoln Hibbard was born last spring with birth defects that kept him in neonatal intensive care for 53 days, his parents had to grapple with the haunting question: Why? Because of a study ...
Today’s clinicians use recombinant therapeutic proteins, such as monoclonal antibodies, to treat many diseases, from autoimmune disorders to cancer and beyond. Nonetheless, sequence variants (SVs), ...
Morning Overview on MSN
New protein sequencing method offers clues to life’s early chemistry
A team of researchers has built a new protein sequencing workflow that pairs mirror proteases with deep learning software to ...
A problem doesn't last a lifetime. But how you deal with it can make it linger for years without resolution. In my studies about the topic, I've identified that, in addition to everything that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results